Document ID: FDA-2014-N-1732-0001
Agency: fda
Document Type: Notice
Title: Food Advisory Committee; Notice of Meeting; Amendment of Notice
Posted Date: 2014-11-13T05:00Z

[Federal Register Volume 79, Number 219 (Thursday, November 13, 2014)]
[Notices]
[Pages 67438-67439]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-26823]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2014-N-1732]

Food Advisory Committee; Notice of Meeting; Amendment of Notice

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing an 
amendment to the notice of the meeting of the Food Advisory Committee. 
This meeting was announced in the Federal Register of August 19, 2014. 
The amendment is being made to add an ADDRESSES section and to reflect 
a change in the Agenda. There are no other changes.

FOR FURTHER INFORMATION CONTACT: Karen Strambler, Center for Food 
Safety and Applied Nutrition, Food and Drug Administration, 5100 Paint 
Branch Pkwy., College Park, MD 20740, 240-402-2589, FAX: 301-436-2637, 
email: FoodAdvisoryCommittee@fda.hhs.gov, or FDA Advisory Committee 
Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC 
area) and follow the prompts to the desired Center or product area. 
Please call the Information Line for up-to-date information on this 
meeting.

SUPPLEMENTARY INFORMATION: In the Federal Register of August 19, 2014 
(79 FR 49091), FDA announced that a meeting of the Food Advisory

[[Page 67439]]

Committee would be held on December 16-17, 2014. The ADDRESSES portion 
of the document is to read as follows:

ADDRESSES: FDA is opening a docket for public comment on this meeting. 
The docket will open for public comment on November 13, 2014. The 
docket will close on January 15, 2014. Interested persons may submit 
either electronic comments regarding this meeting to http://www.regulations.gov or written comments to the Division of Dockets 
Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, 
Rm. 1061, Rockville, MD 20852. It is only necessary to send one set of 
comments. Identify comments with the docket number found in brackets in 
the heading of this document. Received comments may be seen in the 
Division of Dockets Management between 9 a.m. and 4 p.m., Monday 
through Friday, and will be posted to the docket at http://www.regulations.gov. All comments received will be posted without 
changes, including any personal information provided. Comments received 
on or before December 1, 2014, will be provided to the committee before 
the meeting.
    On page 49091, in the second column, the Agenda portion of the 
document is changed to read as follows:
    Agenda: The committee will discuss how risk assessments should 
account for the susceptibility to the effects of a particular chemical 
exposure because of factors such as genetics, age, sex, and health 
status and the circumstances under which FDA would decide to conduct a 
separate risk assessment for these groups.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. app. 2) and 21 CFR part 14, relating to the advisory committees.

    Dated: November 7, 2014.
Jill Hartzler Warner,
Associate Commissioner for Special Medical Programs.
[FR Doc. 2014-26823 Filed 11-12-14; 8:45 am]
BILLING CODE 4164-01-P